OTC Evolution For Prestige Brands Combines Near- And Long-Term Strategies
This article was originally published in The Pink Sheet
Executive Summary
BC, Goody's, Monistat marketer boosts domestic and international OTC revenues immediately with C.B. Fleet acquisition, looks ahead to manufacturing expansion.
You may also be interested in...
Prestige Consumer Healthcare Grows Global View
Overall revenues up 2.6% for October-December to $282.7m as, for second consecutive quarter, PCH reported international sales driving growth. International grew nearly 20% to $46.2m, while North America sales were down for second straight period.
Prestige Brands Acquires C.B. Fleet, Boosts Women’s OTC Platform
Prestige Brands makes the deal three weeks after divesting the slower-selling Massengill douche brand and as it makes a top marketing priority of growing sales of its Monistat yeast treatment line.
Prestige Brands Prepares To Weather Retailers' Inventory Storm
The firm's sales of BC, Goody's, Monistat and other consumer health care brands grow 4.3% in North America and 17.8% internationally in its latest quarter. CEO Ron Lombardi says Prestige Brands expects lower volume orders from retailers during the current quarter and early 2017.